Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

Lancet

Volumn 362, Issue 9377, 2003, Pages 30-37

  Maiuri, Luigi ^a,b   Ciacci, Carolina ^b   Ricciardelli, Ida ^a,b   Vacca, Loredana ^b   Raia, Valeria ^b   Auricchio, Salvatore ^b,c   Picard, Jean ^d   Osman, Mohamed ^a   Quaratino, Sonia ^e   Londei, Marco ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Europ Lab Invest Food Induced D   (Italy)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD83 ANTIGEN; CYCLOOXYGENASE 2; EPITOPE; GLIADIN; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; SYNAPTOPHYSIN;

ADULT; APOPTOSIS; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN VITRO STUDY; INTESTINE CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLING; SIGNAL TRANSDUCTION; SMALL INTESTINE DISEASE; T LYMPHOCYTE; TISSUE CULTURE;

EID: 0038501062     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13803-2     Document Type: Article

References (30)

1. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 119:2000;234-242.
2. Sollid L.M. Molecular basis of celiac disease. Annu Rev Immunol. 18:2000;53-81.
3. Arentz-Hansen H., Korner R., Molberg O., et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 191:2000;603-612.
4. Shan L., Molberg O., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science. 297:2002;2275-2279.
5. Halstensen T.S., Scott H., Fausa O., Brandtzaeg P. Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no crypt-cell hyperplasia. Scand J Immunol. 38:1993;581-590.
6. Maiuri L., Picarelli A., Boirivant M., et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology. 110:1996;1368-1378.
7. Maiuri L., Auricchio S., Coletta S., et al. Blockage of T-cell costimulation inhibits T-cell action in celiac disease. Gastroenterology. 115:1998;564-572.
8. Maiuri L., Ciacci C., Auricchio S., Brown V., Quaratino S., Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology. 119:2000;996-1006.
9. Shidrawi R.G., Day P., Przemioslo R., Ellis H.J., Nelufer J.M., Ciclitira P.J. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol. 30:1995;758-763.
10. Fehniger T.A., Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood. 97:2001;14-32.
11. Lohmann T., Hawa M., Leslie R.D., Lane R., Picard J., Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet. 356:2000;31-35.
12. Subbarayan V., Sabichi A.L., Llansa N., Lippman S.M., Menter D.G. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res. 61:2001;2720-2726.
13. Hmama Z., Gabathuler R., Jefferies W.A., de Jong G., Reiner N.E. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J Immunol. 161:1998;4882-4893.
14. Meagher L., Mahiouz D., Sugars K., et al. Measurement of mRNA for E-selectin, VCAM-1 and ICAM-1 by reverse transcription and the polymerase chain reaction. J Immunol Methods. 175:1994;237-246.
15. Quaratino S., Duddy L.P., Londei M. Fully competent dendritic cells as inducers of T cell anergy in autoimmunity. Proc Natl Acad Sci USA. 97:2000;10911-10916.
16. de Ritis G., Auricchio S., Jones H.W., Lew E.J., Bernardin J.E., Kasarda D.D. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology. 94:1988;41-49.
17. Maiuri L., Ciacci C., Raia V., et al. FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut. 48:2001;418-424.
18. Cuenda A., Rouse J., Doza Y.N., et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
19. Hempel S.L., Monick M.M., Hunninghake G.W. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 93:1994;391-396.
20. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA. 93:1996;2588-2592.
21. Ziegler S.F., Ramsdell F., Alderson M.R. The activation antigen CD69. Stem Cells. 12:1994;456-465.
22. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 73:1993;5-8.
23. Medzhitov R., Janeway C.A. Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol. 9:1997;4-9.
24. Matzinger P. The danger model: a renewed sense of self. Science. 296:2002;301-305.
25. Marsh M.N., Morgan S., Ensary A., Wardle T., Lobley T., Auricchio S. In vivo activity of peptides 31-43, 44-55, 56-68 of a-gliadin in gluten sensitive enteropathy (GSE). Gastroenterology. 108:1995;A871.
26. Sturgess R., Day P., Ellis H.J., et al. Wheat peptide challenge in coeliac disease. Lancet. 343:1994;758-761.
27. McAdam S.N., Sollid L.M. Getting to grips with gluten. Gut. 47:2000;743-745.
28. Cammarota G., Cuoco L., Cianci R., Pandolfi F., Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet. 356:2000;1494-1495.
29. Greco L., Romino R., Coto I., et al. The first large population based twin study of coeliac disease. Gut. 50:2002;624-628.
30. Hommes D., van den Blink B., Plasse T., et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology. 122:2002;7-14.